Almirall's 17th Skin Academy highlights scientific advances in inflammatory skin diseases and skin cancer, patient‑reported outcomes, and holistic care in medical dermatology
Publisher
Spain
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on almirall.com
Leave the platform to read the original full article on the publisher site.
Source: Almirall (Global)
Scope: Industry
Related coverage
More related coverage
View latest results
3 . 24 . 2026Press releaseAAD 2026: Galderma showcases latest evidence supporting its full-spectrum, science-driven solutions for diverse skin needs
From its Therapeutic Dermatology portfolio, Galderma will present data on the efficacy and safety of...
3 . 23 . 2026News storyAAD 2026: Galderma’s scientific presentations
Galderma will present the latest updates on its innovative cross-dermatology portfolio at the 2026 A...
3 . 20 . 2026Press releaseGalderma publishes invitation and agenda for its 2026 Annual General Meeting
The Board of Directors proposes a dividend of 0.35 CHF per registered shareHarry Kirsch proposed as...